Efficacy and Safety of Mate Extracts on Decrement of Body and Abdominal Fat in Obese Subjects
- Conditions
- Obesity
- Interventions
- Dietary Supplement: Mate extractDietary Supplement: Placebo
- Registration Number
- NCT01778257
- Lead Sponsor
- Chonbuk National University Hospital
- Brief Summary
Obesity is a major health issue worldwide; there is a constant raise in obesity related death each year.
- Detailed Description
The primary aim of the study was to investigate the effect of Mate extracts in Korean subjects on body fat and abdominal fat, double blind, placebo-controlled clinical trial.
Thirty obesity subjects with BMI ≥ 25 kg/㎡ and waist-hip ratio (WHR)≥ 0.90 for men and ≥ 0.85 for women were for 12 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- Volunteers aged 19 to 65 years
- 25 kg/m2 ≤ BMI ≥35 kg/m2
- Ability to give informed consent
- Significant variation in weight (more 10%) in the past 3 month
- Cardiovascular disease, neurologic or psychiatric disease, renal, pulmonary and hepatic abnormalities
- History of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease (Crohn's disease) or gastrointestinal surgery (a caesum or enterocele surgery are included)
- Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the sutdy
- Allergic or hypersensitive to any of the ingredients in the test products
- Pregnancy or breast feeding
- Used antipsychosis drugs therapy within past 2 months
- History of alcohol or substance abuse (21 units/week over)
- Participation in any other clinical trials within past 3 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mate extracts group Mate extract Mate extract(3150 mg/day)for 12 weeks Placebo group Placebo Placebo (3150 mg/day) for 12 weeks
- Primary Outcome Measures
Name Time Method Changes in body and abdominal fat body fat: baseline, 6 weeks and 12 weeks, abdominal fat of CT: baseline and 12 weeks
- Secondary Outcome Measures
Name Time Method Changes in anthropometric parameters(weight, BMI, waist and hip circumference) baseline, 6 weeks and 12 weeks Changes in blood lipid profile(total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, free fatty acid) baseline, 6 weeks and 12 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.